Curie Capital
Venture capitalAmsterdam · Seed–Series A · 8 people tracked
Investment thesis
Curie Capital backs early-stage Life Sciences companies, investing at Seed and Series A stages in biotechnology, pharmaceutical, and medical technology firms typically focused on therapeutics, diagnostics, or class IIb and III medical devices. The firm typically leads rounds and syndicates alongside experienced co-investors, supporting portfolio companies with hands-on operational expertise and network access. Under its current fund (Curie Capital 3), it complies with RVO seed capital regulations and invests only in companies with a Dutch headquarters that have not raised more than €3.5 million in equity and/or convertible loans.
Source: firm website, verified Aug 3, 2026.
Team · 8 people
from the firm's website & public directories
What they invest in
from 7 of 7 portfolio companiesBiotech ×6Healthtech ×4Medical Devices ×4AI & Machine Learning ×1Hardware ×1Longevity ×1
HQs:Netherlands×4
Investments · 7 tracked
founders shown can be your intro pathAllero Therapeutics develops non-invasive immunotherapies for immune-mediated disorders such as autoimmune and allergic diseases and anti-drug antibody (ADA) responses.
BiotechHealthtech
Avidicure develops "Actibody", a triple-agonistic antibody platform built on a human IgG scaffold designed to activate the innate and adaptive immune system for treating oncology and autoimmune diseases.
AI & Machine LearningBiotech
Co-investorsBioGeneration VenturesEQT Life SciencesBOMKurma PartnersV-Bio Ventures
Citryll is a biotech company developing CIT-013, a first-in-class monoclonal antibody that targets Extracellular Traps (ETs) to treat immune-mediated inflammatory diseases, with a focus on rheumatoid arthritis and hidradenitis suppurativa.
BiotechHealthtechMedical DevicesOss, NL
Co-investorsBOMNovartis Venture FundPureos BioventuresBioGeneration VenturesForbion
Cleara Biotech is a biopharmaceutical R&D company developing peptide-based therapies that selectively eliminate cells with impaired p53 signaling, targeting cancer and chronic diseases.
BiotechLongevityMedical Devices
Co-investorsCoastCapKorify Capital
Laigo Bio develops targeted protein degradation therapies using its SureTACs (Surface Removal Targeting Chimeras) platform, which uses bispecific antibodies to direct cell-surface proteins toward lysosomal degradation via membrane-bound E3 ligases.
BiotechHealthtech
Co-investorsAngelini VenturesKurma Partners
Sirius Medical develops surgical marker navigation technology, including the Pintuition system with a tumor marker, detection probe, and GPSDetect navigation software that provides real-time audio and visual guidance to locate and remove tumors such as breast cancers.
HardwareHealthtechMedical Devices
TargED Biopharmaceuticals is a Netherlands-based biotechnology company developing first-in-class biological drugs that use small antibodies (VHH) to deliver enzymes to sites of thrombosis for targeted thrombolysis.
BiotechMedical Devices
Co-investorsAndera PartnersFund+Hadean VenturesRotripBioGeneration VenturesInkef+1 more
Portfolio news
latest coverage across their companiesSirius · sharecast.com · Aug 18, 2026
Avidicure · avidicure.com · Jun 27, 2025
Frequently asked questions
- How many investments has Curie Capital made?
- Curie Capital has 7 tracked investments.
- What stage does Curie Capital invest at?
- Curie Capital invests at the Seed, Series A stages.
- What sectors does Curie Capital focus on?
- Curie Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Curie Capital located?
- Curie Capital is headquartered in Amsterdam, NL.
- Does Curie Capital lead rounds?
- Yes, Curie Capital leads investment rounds.
- Who does Curie Capital co-invest with?
- Curie Capital most often shares deals with BOM, Kurma Partners, Rotrip, among 12 tracked co-investors.
Images
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.